HIC
OGN icon

Hamrick Investment Counsel’s Organon & Co OGN Stock Holding History

Hamrick Investment Counsel’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21K Hold
89
– – ﹤0.01% 180
2026
Q1 		$534 Hold
89
– – ﹤0.01% 349
2025
Q4 		$639 Buy
+89
New +$703 ﹤0.01% 180

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Hamrick Investment Counsel's OGN Position: Q2 2026 in Review

Hamrick Investment Counsel held its Organon & Co (OGN) position steady in Q2 2026 at 89 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #180.

Hamrick Investment Counsel first reported a position in OGN in Q4 2025 and has held it in 3 quarters since. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Hamrick Investment Counsel held 89 shares of Organon & Co worth $1.21K as of Q2 2026.
  • Hamrick Investment Counsel left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Hamrick Investment Counsel's portfolio in Q2 2026, its #180 holding.
  • Hamrick Investment Counsel first reported a position in Organon & Co in Q4 2025 and has held it in 3 quarters since.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.